The content on this site is intended for healthcare professionals only
Giving abatacept after checkpoint inhibitors can improve immunotherapy responses...
Dr Stephen Mok - The University of Texas MD Anderson Cancer Center, Houston, USA
19 May 2022
Intratumoral BO-112 with pembrolizumab shows benefit in advanced melanoma refrac...
Dr Iván Márquez-Rodas - Hospital General Universitario Gregorio Marañón, Madrid,...
21 Apr 2022
OncoAlert Colloquium Day 6: Gynaecological oncology, IGCS and ESO
Dr Don Dizon, Dr Allison Betof Warner, Dr Giancarlo Pruneri, Dr Pierfrancesco Fr...
19 Jan 2022
OncoAlert Colloquium Day 5: SWOG, OncoAlliance and more
Dr John Haanen, Dr Vivek Subbiah, Dr Christian Rolfo, Dr Jessica Hwang, Dr Nagla...
19 Jan 2022
Significance of gut microbiota in patients receiving CAR T cell immunotherapy
Prof Marco Ruella - University of Pennsylvania, Philadelphia, USA
17 Dec 2021
Exceptional response to oral metronomic chemotherapy in a rare case of sinonasal...
Dr Akhil Kapoor - Tata Memorial Hospital, Mumbai, India
21 Sep 2021
KEYNOTE-716: Adjuvant pembrolizumab prolongs recurrence-free survival in resecte...
Dr Jason Luke - UPMC Hillman Cancer Center, Pittsburgh, USA
18 Sep 2021
ESMO President: What to watch for at ESMO 2021
Prof Solange Peters - ESMO President
17 Sep 2021
Vaccinations in myeloma patients including for COVID-19
Prof Heinz Ludwig - Wilhelminen Cancer Research Institute, Vienna, Austria
31 Aug 2021
PrE0807: Neoadjuvant nivolumab without or with lirilumab in cisplatin-ineligible...
Dr Petros Grivas - Seattle Cancer Care Alliance, Seattle, USA
22 Jun 2021
CheckMate067 outcomes: Nivolumab plus ipilimumab in advanced melanoma
Dr Jedd Wolchok - Memorial Sloan Kettering Center, New York, USA
9 Jun 2021
LEAP-004: Lenvatinib + pembrolizumab for patients with advanced melanoma and con...
Dr Ana Arance - Hospital Clínic de Barcelona, Barcelona, Spain
8 Jun 2021